• user avatar
    Congratulations to Cynthia Chmielewski who won a CURE#Myeloma Hero’s award for her work leading HealthTree University. She is an amazing individual and advocate. #HealthTreeMM #mmsm
  • user avatar
    This was super exciting to increase the awareness of myeloma, especially since it's myeloma awareness month. We as patients play an important part in improving our own care and accelerating research towards a cure. #mmsm
    "You can either let it destroy, you can let it define you... or you can let it strengthen you and look at it as an opportunity to serve other people," says Jenny Ahlstrom, who was diagnosed with myeloma and is now raising awareness for the rare cancer.
    00:00
  • user avatar
    Reflections on ten years with a multiple myeloma diagnosis. #mmsm myelomacrowd.org/ten-years-of-a…
  • user avatar
    Thx for having us on the @Todayshow! Help cure myeloma faster by sharing the Dana Farber @PromiseStudy. largest screening study in the world for MM. Open to all African Americans and family members of MM patients @alroker @craigmelvin @DylanDreyerNBC @SheinelleJones Pls RT
  • user avatar
    Presenting research with @ManniMD1 at #asco22 on what a cure means of n #myeloma
  • user avatar
    Headed to #ASCO23? Join #MultipleMyeloma experts @Myeloma_Doc, @BiranNoam & @AjayNookaMD for MasterClass & Case Forum event produced in collaboration with @PeerView! TOMORROW 6/3 at 6:30 PM CDT in Chicago (or online)! buff.ly/3MEu0Qp #Immunotherapy #MedEd #MedTwitter
  • user avatar
    Losing fellow myeloma advocates is indescribably hard. In tribute to the love and service of Cherie Rineker, Bob Regello and Bob Tufts #mmsm #myeloma myelomacrowd.org/on-loss-and-lo…
  • user avatar
    New anti-CD38 monoclonal antibody Sarclisa (isatuximab) is now FDA approved for relapsed multiple #myeloma. Great to have another approved treatment for patients with fewer options. #mmsm myelomacrowd.org/new-cd38-monoc…
  • user avatar
    Looking to learn how to address dosing, scheduling, patient preparedness, & toxicities, when using antibody & #Immunotherapy tx options for pts with #MultipleMyeloma? Join @Myeloma_Doc, @BiranNoam & @AjayNookaMD on 6/3 at 6:30 PM CDT at #ASCO23 buff.ly/3MEu0Qp @PeerView
  • user avatar
    The first myeloma CAR T therapy is expected to be approved by the FDA by April 2021 and more are on the way. Learn why specialists are excited about this new generation of treatment from the MCRT on October 31st. myelomacrowd.org/mcrt-webcast-t…
  • user avatar
    After third relapse, BCMA options should be considered. Blenrep, Abecma or Carvykti are all FDA approved. ⁦@ninashah33#mmsm #ASCO22 #PeerView
  • user avatar
    Great talk by ⁦@tombrokaw⁩ at #ASH18. Thank you for bringing awareness to myeloma! Here with amazing patient advocates providing support for others and creating tools like healthtree.org to build greater community and faster cures. #mmsm
  • user avatar
    Join the #MultipleMyeloma experts @Myeloma_Doc, @BiranNoam & @AjayNookaMD at #ASCO23 & get a comprehensive update on the latest efficacy & safety data with CD38 antibodies, BCMA CAR-T, & BCMA & non-BCMA options for MM on 6/3. Produced with @PeerView! buff.ly/3MEu0Qp
  • user avatar
    Subcutaneous Daratumumab receives FDA approval for multiple #myeloma patients. Great news! #mmsm myelomacrowd.org/subcutaneous-d…